Lin, F., Kaminski, H. J., Conti-Fine, B. M., Wang, W., Richmonds, C., & Medof, M. E. (2002). Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection. American Society for Clinical Investigation.
Chicago Style aipamenaLin, Feng, Henry J. Kaminski, Bianca M. Conti-Fine, Wei Wang, Chelliah Richmonds, and M. Edward Medof. Markedly Enhanced Susceptibility to Experimental Autoimmune Myasthenia Gravis in the Absence of Decay-accelerating Factor Protection. American Society for Clinical Investigation, 2002.
MLA aipamenaLin, Feng, et al. Markedly Enhanced Susceptibility to Experimental Autoimmune Myasthenia Gravis in the Absence of Decay-accelerating Factor Protection. American Society for Clinical Investigation, 2002.